TrialThe Lancet. Haematology2022

Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.

Nicholas Crombie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.